|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidenceand mortality worldwide: Sources, methods and
majorpatterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H,
Zou X and He J: Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 26:48–58. 2014.PubMed/NCBI
|
|
3
|
Ferlay J, Shine HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wadhwa R, Taketa T, Sudo K, Blum MA and
Ajani JA: Modern oncological approaches to gastric adenocarcinoma.
Gastroenterol Clin North Am. 42:359–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colmont CS, Harding KG, Piguet V and Patel
GK: Human skin cancer stem cells: A tale of mice and men. Exp
Dermatol. 21:576–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reya T, morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gu G, Yuan J, Wills M and Kasper S:
Prostate cancer cells with stem cell characteristics reconstitute
the original human tumor in vivo. Cancer Res. 67:4807–4815. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye F, Zhou C, Cheng Q, Shen J and Chen H:
Stem-cell-abundant proteins Nanog, Nucleostemin and musashi1 are
highly expressed in malignant cervical epithelial cells. BMC
Cancer. 8:1082008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fairbanks DJ and Maughan PJ: Evolution of
the NANOG pseudogene family in the human and chimpanzee genomes.
BMC Evol Biol. 6:122006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Wang X, Chen B, Suo G, Zhao Y,
Duan Z and Dai J: Expression of Nanog gene promotes NIH3T3 cell
proliferation. Biochem Biophys Res Commun. 338:1098–1102. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hamaguchi M, Meth JL, von Klitzing C, Wei
W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC and Wigler MH:
DBC2, A candidate for a tumor suppressor gene involved in breast
cancer. Proc Natl Acad Sci USA. 99:13647–13652. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JE, Chen J and Lou Z: p30 DBC is a
potential regulator of tumorigenesis. Cell Cycle. 8:2932–2935.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH,
Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, et al: Expression of
DBC1 and SIRT1 is associated with poor prognosis of gastric
carcinoma. Clin Cancer Res. 15:4453–4459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hiraike H, Wada-Hiraike O, Nakagawa S,
Koyama S, Miyamoto Y, Sone K, Tanikawa M, Tsuruga T, Nagasaka K,
Matsumoto Y, et al: Identification of DBC1 as a transcriptional
repressor for BRCA1. Br J Cancer. 102:1061–1067. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang Y, Jung WY, Lee H, Lee E, Kim A and
Kim BH: Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma.
Korean J Pathol. 46:523–531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Gu Y, Sha S, Kong X, Zhu H, Xu B,
Li Y and Wu K: DBC1 is over-expressed and associated with poor
prognosis in colorectal cancer. Int J Clin Oncol. 19:106–112. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bae JS, Park SH, Kim KM, Kwon KS, Kim CY,
Lee HK, Park BH, Park HS, Lee H, Moon WS, et al: CK2α
phosphorylates DBC1 and is involved in the progression of gastric
carcinoma and predicts poor survival of gastric carcinoma patients.
Int J Cancer. 136:797–809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao J, Meng FJ, Li L, Lu C, Zhou J, Cheng
H, Chen W, Chen C and Xu KL: Expression of NANOG gene in acute
lymphoblastic leukemia cells and construction of lentiviral vector
carrying NANOG specific shRNA. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
22:275–279. 2014.(In Chinese). PubMed/NCBI
|
|
22
|
Qin B, Minter-Dykhouse K, Yu J, Zhang J,
Liu T, Zhang H, Lee S, Kim J, Wang L and Lou Z: DBC1 functions as a
tumor suppressor by regulating p53 stability. Cell Rep.
10:1324–1334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao J, Chen C, Zeng L, Li L, Li Z and Xu
K: Engineered regulatory T cells prevent graft-versus-host disease
while sparing the graft versus-leukemia effect after bone marrow
transplantation. Leuk Res. 34:1374–1382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takaishi S, Okumura T and Wang TC: Gastric
cancer stem cells. J Clin Oncol. 26:2876–2882. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang Z, Liu Y and Wang C: Oncogenic
NANOGP8 expression regulates cell proliferation and migration
through the Akt/mTOR signaling pathway in human gastric
cancerSGC-7901cell line. Onco Targets Ther. 9:4859–4866. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Wang X, Li M, Han J, Chen B, Wang
B and Dai J: NANOGP8 is a retrogene expressed in cancers. FEBS J.
273:1723–1730. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uchino K, Hirano G, Hirahashi M, Isobe T,
Shirakawa T, Kusaba H, Baba E, Tsuneyoshi M and Akashi K: Human
Nanog pseudogene8 promotes the proliferation of gastrointestinal
cancer cells. Exp Cell Res. 318:1799–1807. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and NANOG in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Booth HA and Holland PW: Eleven daughters
of NANOG. Genomics. 84:229–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zannini L, Buscemi G, Kim JE, Fontanella E
and Delia D: DBC1 phosphorylation by ATM/ATR inhibits SIRT1
deacetylase in response to DNA damage. J Mol Cell Biol. 4:294–303.
2012. View Article : Google Scholar : PubMed/NCBI
|
